2 12 August 2025 false false false false true false false false false false false true false false false false false false No description of principal activity 2023-12-01 Sage Accounts Production Advanced 2023 - FRS102_2023 1,205,964 1,205,964 1,205,964 xbrli:pure xbrli:shares iso4217:GBP 04084631 2023-12-01 2024-11-30 04084631 2024-11-30 04084631 2023-11-30 04084631 2022-12-01 2023-11-30 04084631 2023-11-30 04084631 2022-11-30 04084631 core:Subsidiary1 2023-12-01 2024-11-30 04084631 core:Subsidiary2 2023-12-01 2024-11-30 04084631 bus:RegisteredOffice 2023-12-01 2024-11-30 04084631 bus:OrdinaryShareClass1 2023-12-01 2024-11-30 04084631 bus:LeadAgentIfApplicable 2023-12-01 2024-11-30 04084631 bus:Director1 2023-12-01 2024-11-30 04084631 bus:Director2 2023-12-01 2024-11-30 04084631 core:ShareCapital 2024-11-30 04084631 core:ShareCapital 2023-11-30 04084631 core:CapitalRedemptionReserve 2024-11-30 04084631 core:CapitalRedemptionReserve 2023-11-30 04084631 core:RetainedEarningsAccumulatedLosses 2024-11-30 04084631 core:RetainedEarningsAccumulatedLosses 2023-11-30 04084631 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 04084631 core:Non-currentFinancialInstruments 2024-11-30 04084631 core:Non-currentFinancialInstruments 2023-11-30 04084631 bus:SmallEntities 2023-12-01 2024-11-30 04084631 bus:Audited 2023-12-01 2024-11-30 04084631 bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 04084631 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 04084631 bus:FullAccounts 2023-12-01 2024-11-30 04084631 bus:OrdinaryShareClass1 2024-11-30 04084631 bus:OrdinaryShareClass1 2023-11-30
COMPANY REGISTRATION NUMBER: 04084631
Invamed Group Limited
Filleted Financial Statements
For the year ended
30 November 2024
Invamed Group Limited
Financial Statements
Year ended 30 November 2024
Contents
Page
Officers and professional advisers
1
Statement of financial position
2
Notes to the financial statements
3
Invamed Group Limited
Officers and Professional Advisers
The board of directors
Mr S. J. Dalton (resigned 13/05/2025)
Mr W. J. Pitt
Registered office
York Road
Bridgend Industrial Estate
Bridgend
CF31 3TB
Auditor
Xeinadin Audit Limited
Chartered accountants & statutory auditor
(Statutory Auditor)
Suite 2D, Building 1
Eastern Business Park
St. Mellons
Cardiff
CF3 5EA
Bankers
National Westminster Bank Plc
28 Adare Street
Bridgend
CF31 1EN
Invamed Group Limited
Statement of Financial Position
30 November 2024
2024
2023
Note
£
£
£
Fixed assets
Investments
5
1,205,964
1,205,964
Current assets
Debtors
6
991,733
1,002,676
Cash at bank and in hand
779,244
768,125
------------
------------
1,770,977
1,770,801
------------
------------
Net current assets
1,770,977
1,770,801
------------
------------
Total assets less current liabilities
2,976,941
2,976,765
------------
------------
Capital and reserves
Called up share capital
7
150,000
150,000
Capital redemption reserve
8
50,000
50,000
Profit and loss account
8
2,776,941
2,776,765
------------
------------
Shareholders funds
2,976,941
2,976,765
------------
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the board of directors and authorised for issue on 12 August 2025 , and are signed on behalf of the board by:
Mr W. J. Pitt
Director
Company registration number: 04084631
Invamed Group Limited
Notes to the Financial Statements
Year ended 30 November 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is York Road, Bridgend Industrial Estate, Bridgend, CF31 3TB.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The directors have assessed whether there are any material uncertainties that may cast significant doubt about the company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue. In assessing whether the going concern assumption is appropriate, the directors have taken in to account all available information about the future, and conclude that the company has adequate resources to to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Revenue recognition
Turnover is measured at the fair value of the consideration received for the provision of services provided to subsidiary undertakings.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
5. Investments
Shares in group
£
Cost
At 1 December 2023 and 30 November 2024
1,205,964
------------
Impairment
At 1 December 2023 and 30 November 2024
------------
Carrying amount
At 30 November 2024
1,205,964
------------
At 30 November 2023
1,205,964
------------
Subsidiaries, associates and other investments
Class of share
Percentage of shares held
Subsidiary undertakings
Roma Medical Aids Limited
Ordinary
100
Invamed Limited
Ordinary
100
The principal activity of Roma Medical Aids Limited was the manufacture and sale of medical aids and rehabilitation equipment. Invamed Limited is a dormant company and RMA Europe BV was dormant company and dissolved on 14 November 2023.
6. Debtors
2024
2023
£
£
Amounts owed by group undertakings
991,712
1,002,655
Other debtors
21
21
---------
------------
991,733
1,002,676
---------
------------
7. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 1 each
150,000
150,000
150,000
150,000
---------
---------
---------
---------
8. Reserves
Capital redemption reserve - This reserve records the nominal value of shares repurchased by the company. Profit and loss account - This reserve records retained earnings and accumulated losses.
9. Summary audit opinion
The auditor's report dated 12 August 2025 was unqualified .
The senior statutory auditor was Catherine Ingram FCCA , for and on behalf of Xeinadin Audit Limited .
10. Related party transactions
The Group has taken advantage of the exemption available under FRS 102 not to disclose transactions between group companies. The company has also taken exemption under the small companies regime from disclosing related party transactions that are either considered immaterial or concluded under normal market conditions.
11. Ultimate controlling party
The ultimate controlling party is Mr W.J. Pitt, by virtue of his ownership of 100% of the issued share capital of the company's parent undertaking, Invamed Holdings Limited, which in turn owns 100% of the issued share capital of the company. Invamed Holding Limited acquired the 100% share capital of Invamed Group Limited post year-end.